These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35601631)

  • 1. Protocol of safe vaccination against COVID-19 in patients with high risk of allergic reactions.
    Romantowski J; Kruszewski J; Solarski O; Bant A; Chciałowski A; Pietrzyk I; Sańpruch P; Górska A; Chełmińska M; Knurowska A; Gawinowska M; Jassem E; Niedoszytko M
    Clin Transl Allergy; 2022 May; 12(5):e12152. PubMed ID: 35601631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.
    Jover Cerdá V; Rodríguez Pacheco R; Doménech Witek J; Alonso Hernández S; Durán García R; Real Panisello M; Marco de la Calle FM
    Allergy Asthma Clin Immunol; 2022 May; 18(1):43. PubMed ID: 35624518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine provocation test outcome in high-risk allergic patients: A retrospective study from a tertiary hospital in Indonesia.
    Koesnoe S; Maria S; Widhani A; Hasibuan AS; Karjadi TH; Khoirunnisa D; Yusuf M; Sumariyono S; Liastuti LD; Djauzi S; Rengganis I; Yunihastuti E
    World Allergy Organ J; 2023 Jan; 16(1):100734. PubMed ID: 36530537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations.
    Wentrys Ł; Stopyra L
    Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
    Worm M; Alexiou A; Bauer A; Treudler R; Wurpts G; Dickel H; Buhl T; Müller S; Jung A; Brehler R; Fluhr J; Klimek L; Mülleneisen N; Pfützner W; Raap U; Roeseler S; Schuh S; Timmermann H; Heine G; Wedi B; Brockow K
    Allergy; 2022 Nov; 77(11):3426-3434. PubMed ID: 35722723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].
    Leonidou Floruß E; Demidova A; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2023 Jul; 74(7):511-519. PubMed ID: 37140637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
    Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
    Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
    Stehlin F; Mahdi-Aljedani R; Canton L; Monzambani-Banderet V; Miauton A; Girard C; Kammermann K; Meylan S; Ribi C; Harr T; Yerly D; Muller YD
    Front Allergy; 2022; 3():818049. PubMed ID: 36238929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
    Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
    JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines.
    Roozen GVT; Granger A; van Binnendijk RS; den Hartog G; Roestenberg M; Visser LG; Roukens AHE
    Vaccine; 2024 Jun; ():. PubMed ID: 38944578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
    Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usability of testing skin reaction applying skin prick tests with Comirnaty (Pfizer, USA) vaccine in detecting the risk of developing post-vaccination immediate hypersensitivity response (anaphylaxis) after administration of this vaccine.
    Gulas E; Bant A; Kruszewski J; Betiuk B; Niedoszytko M; Chciałowski A
    Postepy Dermatol Alergol; 2023 Oct; 40(5):655-660. PubMed ID: 38028424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.
    ALMuhizi F; Fein M; Gabrielli S; Gilbert L; Tsoukas C; Ben-Shoshan M; Copaescu AM; Isabwe GAC
    Ann Allergy Asthma Immunol; 2022 Aug; 129(2):182-188.e1. PubMed ID: 35609744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.